vs
Butterfly Network, Inc.（BFLY）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Butterfly Network, Inc.的1.1倍（$35.5M vs $31.5M），Butterfly Network, Inc.净利率更高（-48.5% vs -304.2%，领先255.7%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 41.0%），Butterfly Network, Inc.自由现金流更多（$7.9M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 33.6%）
Butterfly Network是一家数字医疗企业，主营基于半导体技术的高性价比便携式全身超声设备，产品服务于临床医护人员、医疗机构及居家护理用户，致力于提升全球医疗资源匮乏地区的医学影像可及性。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BFLY vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $31.5M | $35.5M |
| 净利润 | $-15.3M | $-108.1M |
| 毛利率 | 67.3% | 59.8% |
| 营业利润率 | -53.0% | -304.8% |
| 净利率 | -48.5% | -304.2% |
| 营收同比 | 41.0% | 681.7% |
| 净利润同比 | 15.5% | 39.6% |
| 每股收益（稀释后） | $-0.06 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $31.5M | $35.5M | ||
| Q3 25 | $21.5M | $5.2M | ||
| Q2 25 | $23.4M | $19.2M | ||
| Q1 25 | $21.2M | $14.7M | ||
| Q4 24 | $22.4M | $4.5M | ||
| Q3 24 | $20.6M | $26.1M | ||
| Q2 24 | $21.5M | $14.4M | ||
| Q1 24 | $17.7M | $13.8M |
| Q4 25 | $-15.3M | $-108.1M | ||
| Q3 25 | $-34.0M | $-162.3M | ||
| Q2 25 | $-13.8M | $-171.9M | ||
| Q1 25 | $-14.0M | $-202.5M | ||
| Q4 24 | $-18.1M | $-178.9M | ||
| Q3 24 | $-16.9M | $-95.8M | ||
| Q2 24 | $-15.7M | $-97.5M | ||
| Q1 24 | $-21.8M | $-91.4M |
| Q4 25 | 67.3% | 59.8% | ||
| Q3 25 | -17.5% | -183.8% | ||
| Q2 25 | 63.7% | -4.9% | ||
| Q1 25 | 63.0% | -48.0% | ||
| Q4 24 | 61.5% | -181.4% | ||
| Q3 24 | 59.5% | 53.7% | ||
| Q2 24 | 58.6% | 36.2% | ||
| Q1 24 | 58.2% | 19.1% |
| Q4 25 | -53.0% | -304.8% | ||
| Q3 25 | -163.5% | -3327.6% | ||
| Q2 25 | -68.9% | -916.8% | ||
| Q1 25 | -87.0% | -1297.9% | ||
| Q4 24 | -77.5% | -4042.4% | ||
| Q3 24 | -83.9% | -377.1% | ||
| Q2 24 | -80.2% | -697.4% | ||
| Q1 24 | -128.1% | -698.4% |
| Q4 25 | -48.5% | -304.2% | ||
| Q3 25 | -158.1% | -3135.3% | ||
| Q2 25 | -59.2% | -894.2% | ||
| Q1 25 | -65.8% | -1373.3% | ||
| Q4 24 | -81.0% | -3935.5% | ||
| Q3 24 | -82.3% | -367.5% | ||
| Q2 24 | -73.1% | -676.6% | ||
| Q1 24 | -123.2% | -662.4% |
| Q4 25 | $-0.06 | $-0.17 | ||
| Q3 25 | $-0.13 | $-0.36 | ||
| Q2 25 | $-0.06 | $-0.41 | ||
| Q1 25 | $-0.06 | $-0.50 | ||
| Q4 24 | $-0.09 | $-0.56 | ||
| Q3 24 | $-0.08 | $-0.34 | ||
| Q2 24 | $-0.07 | $-0.40 | ||
| Q1 24 | $-0.10 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $150.5M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $196.0M | $1.1B |
| 总资产 | $296.5M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $150.5M | $743.3M | ||
| Q3 25 | $144.2M | $659.8M | ||
| Q2 25 | $148.1M | $525.1M | ||
| Q1 25 | $155.2M | $500.5M | ||
| Q4 24 | $88.8M | $594.4M | ||
| Q3 24 | $93.8M | $427.6M | ||
| Q2 24 | $102.1M | $474.3M | ||
| Q1 24 | $112.7M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $196.0M | $1.1B | ||
| Q3 25 | $203.8M | $1.0B | ||
| Q2 25 | $232.8M | $919.1M | ||
| Q1 25 | $239.7M | $933.9M | ||
| Q4 24 | $168.8M | $1.0B | ||
| Q3 24 | $181.8M | $524.6M | ||
| Q2 24 | $194.3M | $584.4M | ||
| Q1 24 | $204.0M | $401.2M |
| Q4 25 | $296.5M | $1.5B | ||
| Q3 25 | $290.0M | $1.4B | ||
| Q2 25 | $313.3M | $1.3B | ||
| Q1 25 | $318.4M | $1.3B | ||
| Q4 24 | $256.1M | $1.4B | ||
| Q3 24 | $265.3M | $726.5M | ||
| Q2 24 | $273.1M | $775.9M | ||
| Q1 24 | $284.3M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $7.9M | $-47.3M |
| 自由现金流率自由现金流/营收 | 25.2% | -133.1% |
| 资本支出强度资本支出/营收 | 3.4% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-16.0M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $9.0M | $-46.1M | ||
| Q3 25 | $-2.9M | $-117.4M | ||
| Q2 25 | $-7.2M | $-76.4M | ||
| Q1 25 | $-11.7M | $-132.0M | ||
| Q4 24 | $-3.1M | $-115.4M | ||
| Q3 24 | $-7.9M | $-59.2M | ||
| Q2 24 | $-10.0M | $-82.2M | ||
| Q1 24 | $-20.7M | $-102.3M |
| Q4 25 | $7.9M | $-47.3M | ||
| Q3 25 | $-3.9M | $-117.6M | ||
| Q2 25 | $-8.1M | $-79.6M | ||
| Q1 25 | $-12.0M | $-133.8M | ||
| Q4 24 | $-3.5M | $-116.7M | ||
| Q3 24 | $-8.3M | $-63.8M | ||
| Q2 24 | $-10.7M | $-83.4M | ||
| Q1 24 | $-21.8M | $-109.0M |
| Q4 25 | 25.2% | -133.1% | ||
| Q3 25 | -18.2% | -2272.5% | ||
| Q2 25 | -34.5% | -413.9% | ||
| Q1 25 | -56.7% | -907.4% | ||
| Q4 24 | -15.8% | -2567.7% | ||
| Q3 24 | -40.5% | -244.6% | ||
| Q2 24 | -50.0% | -578.5% | ||
| Q1 24 | -123.5% | -789.9% |
| Q4 25 | 3.4% | 3.5% | ||
| Q3 25 | 4.7% | 4.7% | ||
| Q2 25 | 3.8% | 16.4% | ||
| Q1 25 | 1.7% | 12.4% | ||
| Q4 24 | 1.8% | 28.6% | ||
| Q3 24 | 2.0% | 17.5% | ||
| Q2 24 | 3.4% | 8.2% | ||
| Q1 24 | 6.4% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BFLY
| Products | $18.1M | 57% |
| Software And Other Services | $13.4M | 43% |
RXRX
暂无分部数据
